Universal Vapor Jet Corporation (UVJC)

The supplied evidence does not contain any information about Universal Vapor Jet Corporation (UVJC). The only source provided is a press release about Debiopharm's antibody-drug conjugate linker technology, which does not mention UVJC, its products, ownership, headquarters, or history. Because no official-site or Wikipedia brand-sense evidence was supplied, this entry cannot be written as a substantive brand dossier without risking fabrication. The name suggests a corporation connected to vapor-jet technology, but that inference is not supported by the evidence and is therefore not asserted here. This record is flagged for review so that a researcher can supply primary sources (official website, corporate registry filings, or Wikipedia) before the dossier is expanded.

• 2026-10-14

  UVJC launches NovaJet, the first commercial system based on the Universal Vapor Jet Printing platform[2]UVJC发布首款基于Universal Vapor Jet Printing平台的商用系统NovaJetfinance.sina.com.cn

  Reported: 2026-10-14

  Universal Vapor Jet Corporation (UVJC), a wholly-owned subsidiary of Universal Display Corporation (UDC), announced the official launch of NovaJet, the first commercial system built on its proprietary Universal Vapor Jet Printing (UVJP) platform. The solvent-free patterning deposition system is open for ordering and ready for deployment to customer sites; it was developed and manufactured in Singapore and is being showcased to customers at the WESEMiBAY semiconductor expo in Shenzhen, China.

1. 1Debiopharm's Pre-Clinical Proof-Of-Concept Research Unveils the Potential of Novel MultiLINK Linker Technology to Overcome Tumor Resistancefinanznachrichten.de
2. 2UVJC发布首款基于Universal Vapor Jet Printing平台的商用系统NovaJetfinance.sina.com.cn